Twelve outstanding BC Cancer researchers have received significant grants totalling over $4.6 million from the federal government. The funding provided by the Canadian Institutes of Health Research (CIHR) will allow them and their teams to pursue research breakthroughs in cancer, leading to a better understanding of cancer and improved outcomes. The below are the recipients from the 2019 Fall Project Grant results.
Recipients and their projects are:
- Ryan Brinkman and Andrew Weng (Terry Fox Laboratory)
Machine learning for flow cytometry clinical data and trial analysis
- Xiaoyan Jiang (Terry Fox Laboratory)
Targeting a novel miR-185/PAK6 axis to overcome drug-resistance in human leukemia
- William Lockwood (Integrative Oncology) and Peter Stirling (Terry Fox Laboratory)
The effects of smoking marijuana on lung cancer development: implications for screening and early detection
- Brad Nelson (Deeley Research Centre)
Mechanisms of B cell-mediated immunity in human cancer
- Robert Olson, Alison Allan, David Palma, Stuart Peacock (Cancer Control Research), and Scott Tyldesley
A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3
- Ly Vu (Terry Fox Laboratory)
mRNA decay and translational regulation by RNA deadenylation in Myeloid Leukemia
This round, CIHR invested approximately $275 million for 385 research grants across Canada.
CIHR invests approximately $1 billion annually to support science, research and innovation. The multi-year grants are awarded to investigators at any stage in their career as they conduct research projects that cover the full range of health research topics. Grant recipients are leaders in their fields tackling pressing health issues that matter to Canadians.
Congratulations to these recipients for their efforts towards reducing the burden of cancer for all British Columbians.